The Role of CCR3 in Choroidal Neovascularization
Author Information
Author(s): Li Yiwen, Huang Deqiang, Xia Xin, Wang Zhengying, Luo Lingyu, Wen Rong
Primary Institution: Bascom Palmer Eye Institute, University of Miami Miller School of Medicine
Hypothesis
Does CCR3 play a significant role in the development of choroidal neovascularization (CNV)?
Conclusion
CCR3 does not play a significant role in CNV development, while targeting VEGF-A and mTOR is effective in suppressing CNV.
Supporting Evidence
- Blocking CCR3 did not inhibit CNV development in both rat and mouse models.
- VEGF-A neutralizing antibodies significantly suppressed CNV development.
- Rapamycin treatment also effectively inhibited CNV development.
Takeaway
The study found that blocking a specific protein called CCR3 doesn't help with a type of eye disease that causes vision loss, but blocking another protein called VEGF-A does help.
Methodology
The study used a Matrigel-induced CNV model in rats and mice to assess the effects of CCR3 antagonists and neutralizing antibodies on CNV development.
Limitations
The study did not explore other potential roles of CCR3 in different contexts or conditions.
Participant Demographics
Adult Sprague Dawley rats and BALB/c mice were used in the experiments.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website